Filing Details
- Accession Number:
- 0000950170-24-130592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-25 16:30:03
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-25 16:30:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876343 | Lineage Cell Therapeutics Inc. | LCTX | Biological Products, (No Disgnostic Substances) (2836) | 943127919 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509725 | H. Michael Mulroy | C/O Lineage Cell Therapeutics 2173 Salk Avenue, Suite 200 Carlsbad CA 92008 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2024-11-22 | 40,000 | $0.57 | 298,555 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
